TEVA PHARMACEUTICAL INDUSTRIES LIMITED Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High of $2.30 billion as of 2015-12-31, per its 20-F filed 2016-02-11.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh · last filed 2016-02-11
- 2015-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $2.30B.
- 2014-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $2.40B.
| Period end | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |
|---|---|
| 2015-12-31 | $2.30B 20-F · filed 2016-02-11 |
| 2014-12-31 | $2.40B 20-F · filed 2015-02-09 |